ConductScience.org, home

Trial · NCT00335569

Clinical Tolerance and Equivalence of hCG-IBSA vs Recombinant Human Chorionic Gonadotrophin in Women Undergoing In Vitro Fertilisation

NCT00335569, Phase 3, Completed, IBSA Institut Biochimique SA

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Clinical Tolerance and Equivalence of hCG-IBSA vs Recombinant Human Chorionic Gonadotrophin in Women Undergoing In Vitro Fertilisation. Trials, record NCT00335569. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00335569

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Clinical Tolerance and Equivalence of hCG-IBSA vs Recombinant Human Chorionic Gonadotrophin in Women Undergoing In Vitro Fertilisation
NCT number
NCT00335569
Status
Completed
Phases
Phase 3
Enrollment
144 participants, estimated
Lead sponsor
IBSA Institut Biochimique SA
Conditions
Infertility
Interventions
hCG-IBSA
First posted
2006-06-12
Last updated
2011-06-01

Source ClinicalTrials.gov

Registered outcomes6

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryTotal number of oocytes retrieved per patient who received hCG
SecondaryNumber of patients who received hCG with at least one oocyte retrieved, 2PN fertilized oocytes,
Secondary2PN or cleaved embryos, implantation rate per embryo transferred; Serum P and hCG concentration on the days of oocyte retrieval, on day of embryo transfer and on day 5-8 post-hCG;
SecondaryImplantation rate;Pregnancy rate.
SecondaryAdverse Eventsfrom day 1 to 35 +/- 7 days after oocytes retrievalAdverse events were monitored and collected during all the study period
SecondaryIncidence of moderate or severe OHSSFrom the day of hCG injection until 35 +/- 7 days after oocyte retrievalThe incidence moderate or severe of OHSS will be assessed in both treatment groups

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers12

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
1868645BACKGROUNDPubMed
2660037BACKGROUNDPubMed
3119376BACKGROUNDPubMed
3122575BACKGROUNDPubMed
5778792BACKGROUNDPubMed
6012569BACKGROUNDPubMed
6105640BACKGROUNDPubMed
6267989BACKGROUNDPubMed
6419189BACKGROUNDPubMed
9990695BACKGROUNDPubMed

1 to 10 of 12

See all 12 papers

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT00335569

GET https://conductscience.org/api/trials/v1/NCT00335569/registered